Skip to main content

Table 5 Pooled prevalence of antibiotic resistance of Bacillus spp, Staphylococcus spp and Vibrio cholerae-based on the meta-analysis of environmental studies

From: Antimicrobial resistance from a one health perspective in Cameroon: a systematic review and meta-analysis

Bacteria reported in studies

Antimicrobial agents

Number of studies

Pooled prevalence of AMR (95% CI)

Bacillus spp

Beta-lactams

 Amoxicillin

4

83.8 (59.5–94.8)

 Amoxicillin+Clavulanic acid

3

65.9 (48.3–80.0)

 Penicillin

4

64.8 (34.2–86.7)

 Oxacillin

3

81.1 (64.8–90.9)

 Ceftazidime

3

53.4 (30.4–75.1)

 Cefuroxime

3

70.1 (50.6–84.2)

 Cefoxitine

3

88.7 (74.5–95.5)

 Ceftriaxone

3

61.7 (29.9–85.9)

Aminoglycosides

 Gentamicin

3

14.0 (6.6–27.1)

Quinolones

  

 Nalidixic acid

3

45.2 (20.8–72.3)

 Ciprofloxacin

3

28.1 (23.9–32.8)

Nitrofuranes

 Nitrofurantoin

3

60.4 (48.5–71.2)

Sulfonamides & Trimethoprim

 Co-trimoxazole

3

61.6 (38.1–80.7)

Staphylococcus spp

Beta-lactams

 Amoxicillin

4

67.2 (31.1–90.3)

 Amoxicillin+Clavulanic acid

3

59.6 (47.5–70.6)

 Penicillin

5

78.3 (54.3–91.9)

 Oxacillin

3

89.3 (84.2–92.9)

 Ceftazidime

3

69.5 (52.0–82.7)

 Cefoxitine

3

74.7 (62.3–84.1)

 Ceftriaxone

3

83.8 (68.4–92.5)

Quinolones

 Nalidixic acid

3

89.1 (83.7–92.8)

 Ciprofloxacin

4

18.2 (5.9–44.3)

Nitrofuranes

 Nitrofurantoin

3

44.7 (37.9–51.7)

Sulfonamides & Trimethoprim

 Co-trimoxazole

3

62.1 (32.4–84.9)

Vibrio cholerae

Beta-lactams

 Ampicillin

4

53.6 (47.3–59.8)

Phenicols

 Chloramphenicol

4

19.1 (2.4–69.0)

Tetracyclines

 Tetracycline

4

41.60 (14.6–74.9)

  1. AMR Antimicrobial resistance